J. Scott Wolchko - 20 May 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
20 May 2021
Net transactions value
-$1,446,592
Form type
4
Filing time
24 May 2021, 16:01:55 UTC
Next filing
26 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common stock Options Exercise $96,700 +20,000 +5.1% $4.84 413,793 20 May 2021 Direct F1
transaction FATE Common stock Sale $1,543,292 -20,000 -4.8% $77.16* 393,793 20 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (right to buy) Options Exercise -20,000 -31% 44,846 20 May 2021 Common Stock 20,000 $4.84 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
F2 This option is fully vested.
F3 Not applicable.